Documented medical need (BMI 30+ or BMI 27+ with comorbidity) supports prescription
Journal of Food Biochemistry : Cinnamon, an Effective Anti-Obesity Agent: Evidence From an Umbrella Meta-Analysis Avicenna Journal of Phytomedicine : Effects of Cinnamon on Anthropometric Indices and Headache-Related Disability of Patients with Migraine: A Randomized Double-Blind Placebo-Controlled Trial Food Bioscience : Cinnamon Free Phenolic Extract Regulates Glucose Absorption in Intestinal Cells by Inhibiting Glucose Transporters The University of Texas MD Anderson Cancer Center: Weight Loss Injections and Cancer: 6 Questions, Answered Dawn Jackson Blatner, RDN HarperCollins Publishers: The Superfood Swap National Institutes of Health: Cinnamon National Institutes of Health: Dietary Supplements: What You Need to Know Sean Hashmi, MD Medical Reviewer Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California

GLP-1RA drugs, widely used to manage diabetes and obesity, are known to slow gastrointestinal motility, potentially affecting the quality of bowel cleansing necessary for accurate colonoscopy screenings
J Diabetes Invest (2013) 4(4):38292
The product will not be used for diagnostic, therapeutic, or medicinal purposes